Tykerb lapatinib: Phase II data

By WIR Staff | Dec 18, 2006 | 8:00 AM GMT

In an international Phase II trial, 30 of 35 evaluable women (86%)

Read the full 123 word article

How to gain access

Continue reading with a
two-week free trial.